Gilvetmab

Last updated
Gilvetmab
Monoclonal antibody
Type ?
Source Mouse
Target PCDC1
Clinical data
Synonyms PD1
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6578H10212N1766O2023S48
Molar mass 147.9 g/mol

Gilvetmab (INN [1] ) (PD1) is a veterinary monoclonal antibody.

This drug was developed by Merck Sharp & Dohme Corp. [2]

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world.

References

  1. World Health Organization (2016). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 116" (PDF). WHO Drug Information. 30 (4).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Gilvetmab, American Medical Association.